Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Multiple Sclerosis

Free Subscription Articles published in J Neuroimmunol Retrieve available abstracts of 151 articles: HTML format Text format

Single Articles

January 2012
1. KALISZEWSKA A , De Jager PL
   Exploring the role of the epigenome in multiple sclerosis: A window onto cell-specific transcriptional potential.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. VILLOSLADA P , Baranzini S
   Data integration and systems biology approaches for biomarker discovery: Challenges and opportunities for multiple sclerosis.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. FOSTER M , Zivadinov R, Weinstock-Guttman B, Tamano-Blanco M, et al
   Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. STOJKOVIC L , Djuric T, Stankovic A, Dincic E, et al
   The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. PINTO-MEDEL MJ , Garcia-Leon JA, Oliver-Martos B, Lopez-Gomez C, et al
   The CD4(+) T-cell subset lacking expression of the CD28 costimulatory molecule is expanded and shows a higher activation state in multiple sclerosis.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. MANDEL I , Paperna T, Miller A
   Aberrant expression of the apoptosis-related proteins BAK and MCL1 in T cells in multiple sclerosis.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. BORONAT A , Sepulveda M, Llufriu S, Sabater L, et al
   Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. NEVIN RL
   Investigating channel blockers for the treatment of multiple sclerosis: Considerations with mefloquine and carbenoxolone.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
9. CHEN YC , Chen SD, Miao L, Liu ZG, et al
   Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. MULERO P , Caminero AB, Neri Crespo MJ, Fernandez-Herranz R, et al
    Latent tuberculosis seems not to reactivate in multiple sclerosis patients on natalizumab.
    J Neuroimmunol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
11. BUENAFE AC
    Diurnal rhythms are altered in a mouse model of multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. BEYER NH , Lueking A, Kowald A, Frederiksen JL, et al
    Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. ZHONG X , Wang H, Dai Y, Wu A, et al
    Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
    J Neuroimmunol. 2011;240-241:104-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. LAUGEL B , Borlat F, Galibert L, Vicari A, et al
    Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity.
    J Neuroimmunol. 2011;240-241:52-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. DOBSON R , Meier UC, Giovannoni G
    More to come: humoral immune responses in MS.
    J Neuroimmunol. 2011;240-241:13-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. WANG H , Wang K, Zhong X, Dai Y, et al
    Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. NAEGELE M , Tillack K, Reinhardt S, Schippling S, et al
    Neutrophils in multiple sclerosis are characterized by a primed phenotype.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
18. TOEPFNER N , Cepok S, Grummel V, Hemmer B, et al
    The role of the Epstein-Barr Virus receptor CD21 in Multiple Sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. SINGH V , Hintzen RQ, Luider TM, Stoop MP, et al
    Proteomics technologies for biomarker discovery in multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. CHEN M , Chen G, Deng S, Liu X, et al
    IFN-beta induces the proliferation of CD4(+)CD25(+)Foxp3(+) regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. YU X , Burgoon M, Green M, Barmina O, et al
    Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over time.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. ZANOTTI C , Chiarini M, Serana F, Capra R, et al
    Opposite effects of interferon-beta on new B and T cell release from production sites in multiple sclerosis patients.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. GUERAU-DE-ARELLANO M , Alder H, Ozer HG, Lovett-Racke A, et al
    miRNA profiling for biomarker discovery in multiple sclerosis: From microarray to deep sequencing.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
24. KALINOWSKA-LYSZCZARZ A , Pawlak MA, Michalak S, Paprzycki W, et al
    Immune cell NT-3 expression is associated with brain atrophy in multiple sclerosis patients.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. VICHAYA EG , Young EE, Frazier MA, Cook JL, et al
    Social disruption induced priming of CNS inflammatory response to Theiler's virus is dependent upon stress induced IL-6 release.
    J Neuroimmunol. 2011;239.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. VURAL B , Ugurel E, Tuzun E, Kurtuncu M, et al
    Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behcet's disease.
    J Neuroimmunol. 2011;239.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. PEELEN E , Damoiseaux J, Smolders J, Knippenberg S, et al
    Th17 expansion in MS patients is counterbalanced by an expanded CD39(+) regulatory T cell population during remission but not during relapse.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. LOSSIUS A , Vartdal F, Holmoy T
    Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. GIOVANNI F , Domenico P, Alessandro M, Raffaele I, et al
    Circulating CD8(+)CD56(-)perforin(+) T cells are increased in multiple sclerosis patients.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. HUANG XN , Fu J, Wang WZ
    The effects of fasudil on the permeability of the rat blood-brain barrier and blood-spinal cord barrier following experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
31. KNIPPENBERG S , Peelen E, Smolders J, Thewissen M, et al
    Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. KWOK JY , Vaida F, Augst RM, Yu DY, et al
    Mannose binding lectin mediated complement pathway in multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. GAMBUZZA M , Licata N, Palella E, Celi D, et al
    Targeting Toll-like receptors: Emerging therapeutics for multiple sclerosis management.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
34. MALHOTRA S , Morcillo-Suarez C, Brassat D, Goertsches R, et al
    IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. URSHANSKY N , Mausner-Fainberg K, Auriel E, Regev K, et al
    Low and dysregulated production of follistatin in immune cells of relapsing-remitting multiple sclerosis patients.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. BRENNAN KM , Galban-Horcajo F, Rinaldi S, O'Leary CP, et al
    Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. RAINE CS
    John W. Prineas awarded the Order of Australia.
    J Neuroimmunol. 2011;237.
    PubMed     Text format     Related articles   
    
    
    
    
38. LUNDSTROM W , Greiner E, Lundmark F, Westerlind H, et al
    No influence on disease progression of non-HLA susceptibility genes in MS.
    J Neuroimmunol. 2011;237.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
39. VIRTANEN JO , Pietilainen-Nicklen J, Uotila L, Farkkila M, et al
    Intrathecal human herpesvirus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. TOLDI G , Folyovich A, Simon Z, Zsiga K, et al
    Lymphocyte calcium influx kinetics in multiple sclerosis treated without or with interferon beta.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. ZHANG Z , Zhang ZY, Schittenhelm J, Wu Y, et al
    Parenchymal accumulation of CD163(+) macrophages/microglia in multiple sclerosis brains.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. HEIDARI A , Behmanesh M, Sahraian MA, Meshkani R, et al
    The human caveolin 1 gene upstream purine complex and neurodegeneration--a common signature.
    J Neuroimmunol. 2011;236.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. HORAKOVA D , Zivadinov R, Weinstock-Guttman B, Havrdova E, et al
    HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event.
    J Neuroimmunol. 2011;236.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. HOSOKAWA T , Nakajima H, Doi Y, Sugino M, et al
    Increased serum matrix metalloproteinase-9 in neuromyelitis optica: implication of disruption of blood-brain barrier.
    J Neuroimmunol. 2011;236.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. YU X , Green M, Gilden D, Lam C, et al
    Identification of peptide targets in neuromyelitis optica.
    J Neuroimmunol. 2011;236.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. CRANE JM , Rossi A, Gupta T, Bennett JL, et al
    Orthogonal array formation by human aquaporin-4: examination of neuromyelitis optica-associated aquaporin-4 polymorphisms.
    J Neuroimmunol. 2011;236.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
47. SANVITO L , Tomita A, Chihara N, Okamoto T, et al
    Increase of Ki-67+ natural killer cells in multiple sclerosis patients treated with interferon-beta and interferon-beta combined with low-dose oral steroids.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. SAFAVI F , Feliberti JP, Raine CS, Mokhtarian F, et al
    Role of gammadelta T cells in antibody production and recovery from SFV demyelinating disease.
    J Neuroimmunol. 2011;235.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. SAADOUN S , Waters P, Macdonald C, Bridges LR, et al
    T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement.
    J Neuroimmunol. 2011;235.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. KALA M , Miravalle A, Vollmer T
    Recent insights into the mechanism of action of glatiramer acetate.
    J Neuroimmunol. 2011;235.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
51. MIROWSKA-GUZEL D , Gromadzka G, Mach A, Czlonkowski A, et al
    Association of IL1A, IL1B, ILRN, IL6, IL10 and TNF-alpha polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. LEE S , Xu L, Shin Y, Gardner L, et al
    A potential link between autoimmunity and neurodegeneration in immune-mediated neurological disease.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. GORIS A , Fockaert N, Cosemans L, Clysters K, et al
    TNFRSF1A coding variants in multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. CHEN X , Ma X, Jiang Y, Pi R, et al
    The prospects of minocycline in multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. SKARICA M , Eckstein C, Whartenby KA, Calabresi PA, et al
    Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. AHLGREN C , Oden A, Haghighi S, Andersen O, et al
    The effect of live, attenuated measles vaccine and measles infection on measles antibody levels in serum and CSF of patients with multiple sclerosis or clinically isolated syndrome.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. CAMINERO A , Comabella M, Montalban X
    Tumor necrosis factor alpha (TNF-alpha), anti-TNF-alpha and demyelination revisited: an ongoing story.
    J Neuroimmunol. 2011;234.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. HARRER A , Wipfler P, Einhaeupl M, Pilz G, et al
    Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells.
    J Neuroimmunol. 2011;234.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. DUJMOVIC I , Mader S, Schanda K, Deisenhammer F, et al
    Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders.
    J Neuroimmunol. 2011;234.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
60. SMOLDERS J , Thewissen M, Theunissen R, Peelen E, et al
    Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. LI Y , Wang H, Long Y, Lu Z, et al
    Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. GREER JM , McCombe PA
    Role of gender in multiple sclerosis: Clinical effects and potential molecular mechanisms.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. REN Z , Wang Y, Liebenson D, Liggett T, et al
    IRF-1 signaling in central nervous system glial cells regulates inflammatory demyelination.
    J Neuroimmunol. 2011;233.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. TUZUN E , Kurtuncu M, Turkoglu R, Icoz S, et al
    Enhanced complement consumption in neuromyelitis optica and Behcet's disease patients.
    J Neuroimmunol. 2011;233.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. GORI F , Mulinacci B, Massai L, Avolio C, et al
    IgG and IgM antibodies to the refolded MOG(1-125) extracellular domain in humans.
    J Neuroimmunol. 2011;233.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. WANG H , Dai Y, Qiu W, Zhong X, et al
    HLA-DPB1 0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese.
    J Neuroimmunol. 2011;233.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. BARATCHI S , Kanwar RK, Kanwar JR
    Novel survivin mutant protects differentiated SK-N-SH human neuroblastoma cells from activated T-cell neurotoxicity.
    J Neuroimmunol. 2011;233.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
68. BIEGLER BW , Yan SX, Ortega SB, Tennakoon DK, et al
    Clonal composition of neuroantigen-specific CD8+ and CD4+ T-cells in multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. HAGMAN S , Raunio M, Rossi M, Dastidar P, et al
    Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: Prospective clinical and MRI follow-up study.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. ROTONDI M , Stufano F, Lagonigro MS, La Manna L, et al
    Interferon-beta but not Glatiramer acetate stimulates CXCL10 secretion in primary cultures of thyrocytes: A clue for understanding the different risks of thyroid dysfunctions in patients with multiple sclerosis treated with either of the two drugs.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. EBERS GC
    Gene associations - SNPs and function.
    J Neuroimmunol. 2011;232.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
72. OBERMEIER B , Lovato L, Mentele R, Bruck W, et al
    Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. MCFARLAND H
    The importance of clinical trials in unraveling the mysteries of multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. FLEMING JO
    Helminths and multiple sclerosis: Will old friends give us new treatments for MS?
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
75. WENDER M
    Acute disseminated encephalomyelitis (ADEM).
    J Neuroimmunol. 2011;231.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. FAZIO R , Radaelli M, Furlan R
    Neuromyelitis optica: concepts in evolution.
    J Neuroimmunol. 2011;231.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
77. CORREALE J , Farez MF
    The impact of parasite infections on the course of multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. HAEGERT DG , Hackenbroch JD, Duszczyszyn D, Fitz-Gerald L, et al
    Reduced thymic output and peripheral naive CD4 T-cell alterations in primary progressive multiple sclerosis (PPMS).
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. ZAHEDNASAB H , Saadatnia M, Jabalameli MR, Zarkesh-Esfahani H, et al
    Controversial role of MMP-9 gene in MS disease.
    J Neuroimmunol. 2011;230.
    PubMed     Text format     Related articles   
    
    
    
    
80. SAND PG
    CASP8 in MS.
    J Neuroimmunol. 2011;230.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
81. LYSANDROPOULOS AP , Jaquiery E, Jilek S, Pantaleo G, et al
    Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. YU X , Gilden D, Schambers L, Barmina O, et al
    Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. JENSEN CJ , Stankovich J, Butzkueven H, Oldfield BJ, et al
    Common variation in the MOG gene influences transcript splicing in humans.
    J Neuroimmunol. 2010;229.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. RAY A , Mann MK, Basu S, Dittel BN, et al
    A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. SAKURAI T , Kimura A, Yamada M, Koumura A, et al
    Identification of antibodies as biological markers in serum from multiple sclerosis patients by immunoproteomic approach.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
86. ESPOSITO F , Wojcik J, Rodegher M, Radaelli M, et al
    MGAT5 and disease severity in progressive multiple sclerosis.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. GROSS R , Healy BC, Cepok S, Chitnis T, et al
    Population structure and HLA DRB1*1501 in the response of subjects with multiple sclerosis to first-line treatments.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. MILO R , Panitch H
    Combination therapy in multiple sclerosis.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. URSHANSKY N , Mausner-Fainberg K, Auriel E, Regev K, et al
    Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. FRANCIOTTA D , Di Stefano AL, Jarius S, Zardini E, et al
    Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. OLIVER-MARTOS B , Orpez T, Pinto-Medel MJ, Mayorga C, et al
    Gene expression in IFNss signalling pathway differs between monocytes, CD4 and CD8 T cells from MS patients.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. MEOLI EM , Oh U, Grant CW, Jacobson S, et al
    TGF-beta signaling is altered in the peripheral blood of subjects with multiple sclerosis.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. FARINAZZO A , Gini B, Milli A, Ruffini F, et al
    2D immunomic approach for the study of IgG autoantibodies in the experimental model of multiple sclerosis.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. SMITH AW , Doonan BP, Tyor WR, Abou-Fayssal N, et al
    Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
95. PACHNER AR , Li L, Lagunoff D
    Plasma cells in the central nervous system in the Theiler's virus model of multiple sclerosis.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. OFFNER H , Sinha S, Burrows GG, Ferro AJ, et al
    RTL therapy for multiple sclerosis: A Phase I clinical study.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. LOSY J , Kalinowska-Lyszczarz A
    Emerging disease-modifying oral therapies for multiple sclerosis.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. ZHANG Y , Jalili F, Ouamara N, Zameer A, et al
    Glatiramer acetate-reactive T lymphocytes regulate oligodendrocyte progenitor cell number in vitro: role of IGF-2.
    J Neuroimmunol. 2010;227.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. TIAN Y , Apperson ML, Ander BP, Liu D, et al
    Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
100. GUERAU-DE-ARELLANO M , Lovett-Racke AE, Racke MK
     miRNAs in multiple sclerosis: Regulating the regulators.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
101. KAPLAN B , Aizenbud BM, Golderman S, Yaskariev R, et al
     Free light chain monomers in the diagnosis of multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. BENNETT J , Basivireddy J, Kollar A, Biron KE, et al
     Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. BAHREINI SA , Jabalameli MR, Saadatnia M, Zahednasab H, et al
     The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. LINDSEY JW , Hatfield LM
     Epstein-Barr virus and multiple sclerosis: Cellular immune response and cross-reactivity.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. FUSCO C , Guerini FR, Nocera G, Ventrella G, et al
     KIRs and their HLA ligands in Remitting-Relapsing Multiple Sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. CASIRAGHI C , Dorovini-Zis K, Horwitz MS
     Epstein-Barr virus infection of human brain microvessel endothelial cells: A novel role in multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2010
107. AHARONI R , Eilam R, Stock A, Vainshtein A, et al
     Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE.
     J Neuroimmunol. 2010;225.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. MILLONIG A , Hegen H, Di Pauli F, Ehling R, et al
     Natalizumab treatment reduces endothelial activity in MS patients.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. YAMOUT B , Hourani R, Salti H, Barada W, et al
     Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. LORENTZEN AR , Melum E, Ellinghaus E, Smestad C, et al
     Association to the Glypican-5 gene in multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
111. LINK J , Lorentzen AR, Kockum I, Duvefelt K, et al
     Two HLA class I genes independently associated with multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. CONDUCTIER G , Blondeau N, Guyon A, Nahon JL, et al
     The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases.
     J Neuroimmunol. 2010;224.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. LIGOCKI AJ , Lovato L, Xiang D, Guidry P, et al
     A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. DE SANTIS G , Ferracin M, Biondani A, Caniatti L, et al
     Altered miRNA expression in T regulatory cells in course of multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. AUNG LL , Fitzgerald-Bocarsly P, Dhib-Jalbut S, Balashov K, et al
     Plasmacytoid dendritic cells in multiple sclerosis: Chemokine and chemokine receptor modulation by interferon-beta.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2010
116. NISCHWITZ S , Cepok S, Kroner A, Wolf C, et al
     Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. CUCCI A , Barbero P, Clerico M, Ferrero B, et al
     Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. VENKEN K , Hellings N, Hensen K, Rummens JL, et al
     Memory CD4(+)CD127(high) T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. COMABELLA M , Montalban X, Kakalacheva K, Osman D, et al
     B cell expression of the inhibitory Fc gamma receptor is unchanged in early MS.
     J Neuroimmunol. 2010;223.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2010
120. FERNANDEZ M , Montalban X, Comabella M
     Orchestrating innate immune responses in multiple sclerosis: Molecular players.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. NOCITI V , Frisullo G, Marti A, Luigetti M, et al
     Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral Sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. CISNEROS E , Moraru M, de Pablo R, Vilches C, et al
     A method for simple and accurate identification of the multiple sclerosis associated allele HLA-DRB1*1501 in neuroscience research laboratories.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. WATSON CT , Ramagopalan SV, Morrison KM, Ebers GC, et al
     IGHV4-39 deletion polymorphism does not associate with risk or outcome of multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. LA RUSSA A , Cittadella R, De Marco EV, Valentino P, et al
     Single nucleotide polymorphism in the MMP-9 gene is associated with susceptibility to develop multiple sclerosis in an Italian case-control study.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. JAQUIERY E , Jilek S, Schluep M, Le Goff G, et al
     Cytokine mRNA profile of Epstein-Barr virus-stimulated highly differentiated T cells in multiple sclerosis: A pilot study.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. KOVALCHIN J , Krieger J, Genova M, Collins K, et al
     Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2010
127. ZHOU J , Nagarkatti P, Zhong Y, Nagarkatti M, et al
     Immune modulation by chondroitin sulfate and its degraded disaccharide product in the development of an experimental model of multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
128. SWAMINATHAN B , Matesanz F, Cavanillas ML, Alloza I, et al
     Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. MACKAY IR , Anderson WH
     What's in a name? Experimental encephalomyelitis: 'Allergic' or 'autoimmune'
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. INGRAM G , Hakobyan S, Robertson NP, Morgan PB, et al
     Elevated plasma C4a levels in multiple sclerosis correlate with disease activity.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. SAINI H , Fernandez G, Kerr D, Levy M, et al
     Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity.
     J Neuroimmunol. 2010;221.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. HANDEL AE , De Luca GC, Morahan J, Handunnetthi L, et al
     No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. O'CONNOR KC , Lopez-Amaya C, Gagne D, Lovato L, et al
     Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. CAMINA-TATO M , Fernandez M, Morcillo-Suarez C, Navarro A, et al
     Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2010
135. KUHLE J , Regeniter A, Leppert D, Mehling M, et al
     A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein.
     J Neuroimmunol. 2010;220.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. GUREVICH M , Gritzman T, Orbach R, Tuller T, et al
     Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: In-vitro high-throughput gene expression study.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. RODRIGUES DH , Vilela MD, Barcelos LD, Pinho V, et al
     Absence of PI3Kgamma leads to increased leukocyte apoptosis and diminished severity of experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. ASLAM M , Kalluri SR, Cepok S, Kraus V, et al
     The antibody response to oligodendrocyte specific protein in multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. HIROTANI M , Niino M, Fukazawa T, Kikuchi S, et al
     Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. RANE L , Vudattu N, Bourcier K, Graniar E, et al
     Alternative splicing of interleukin-7 (IL-7) and interleukin-7 receptor alpha (IL-7Ralpha) in peripheral blood from patients with multiple sclerosis (MS).
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. DUSZCZYSZYN DA , Williams JL, Mason H, Lapierre Y, et al
     Thymic involution and proliferative T-cell responses in multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2010
142. DOBSON R , Miller RF, Palmer HE, Feldmann M, et al
     Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. KARUSSIS D , Teitelbaum D, Sicsic C, Brenner T, et al
     Long-term treatment of multiple sclerosis with glatiramer acetate: Natural history of the subtypes of anti-glatiramer acetate antibodies and their correlation with clinical efficacy.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. YATES MA , Li Y, Chlebeck P, Proctor T, et al
     Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. PIAZZA F , Difrancesco JC, Fusco ML, Corti D, et al
     Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. ESPOSITO M , Ruffini F, Bellone M, Gagliani N, et al
     Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2010
147. BRYNEDAL B , Wojcik J, Esposito F, Debailleul V, et al
     MGAT5 alters the severity of multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. BERGAMASCHI L , Ban M, Leone MA, Sawcer SJ, et al
     No evidence of association of the rare nsSNP rs35667974 in IFIH1 with multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
149. ALDINUCCI A , Biagioli T, Manuelli C, Repice AM, et al
     Modulating dendritic cells (DC) from immunogenic to tolerogenic responses: a novel mechanism of AZA/6-MP.
     J Neuroimmunol. 2010;218.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
150. JURYNCZYK M , Selmaj K
     Notch: a new player in MS mechanisms.
     J Neuroimmunol. 2010;218.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. MIZRACHI K , Aricha R, Feferman T, Kela-Madar N, et al
     Involvement of phosphodiesterases in autoimmune diseases.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.    Design: